Assignee
NEWAMSTERDAM PHARMA B V
NL·5 granted patents·4 pending applications·10 citations·filing 2021–2025
Top patents by PatentIndex Score
9 records- 0193US11642344B2Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseasesNEWAMSTERDAM PHARMA B V·Filed 2021·Granted May 9, 2023·5 cites·10 claims
- 0287US12006305B2Salts of obicetrapib and processes for their manufacture and intermediates thereofNEWAMSTERDAM PHARMA B V·Filed 2023·Granted Jun 11, 2024·5 cites·27 claims
- 0385US2025228852A1Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseasesNEWAMSTERDAM PHARMA B V·Filed 2024·Application pending·0 cites
- 0483US12186315B2Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseasesNEWAMSTERDAM PHARMA B V·Filed 2023·Granted Jan 7, 2025·0 cites·4 claims
- 0582US2026007669A1Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseasesNEWAMSTERDAM PHARMA B V·Filed 2025·Application pending·0 cites
- 0677US12378221B2Salts of obicetrapib and processes for their manufacture and intermediates thereofNEWAMSTERDAM PHARMA B V·Filed 2024·Granted Aug 5, 2025·0 cites·22 claims
- 0774US12570628B2Salts of obicetrapib and processes for their manufacture and intermediates thereofNEWAMSTERDAM PHARMA B V·Filed 2025·Granted Mar 10, 2026·0 cites·27 claims
- 0857US2024189311A1Combination Therapy of Obicetrapib and Ezetimibe for Use in Statin Intolerant Patients Suffering from Hyperlipidemia or Mixed DyslipidaemiaNEWAMSTERDAM PHARMA B V·Filed 2022·Application pending·0 cites
- 0945US2025186442A1Obicetrapib and Ezetimibe Combination Treatment and Fixed Dose Pharmaceutical CompositionsNEWAMSTERDAM PHARMA B V·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEWAMSTERDAM PHARMA B V files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →